Across TCGA pan-cancer cohorts, VN1R71P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of VN1R71P’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where VN1R71P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types VN1R71P is over-expressed in tumor.
LUAD are the cancer types where VN1R71P tumor–normal differential expression is most reproducible.